AMERICAN CENTURY COMPANIES INC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 748054
KANSAS CITY, MO
Position in CLDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,787,517
+$11,625,364 QoQ
Shares Held
1,042,395
+21.7% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 252 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 86%
Shared 14%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. CLDX ranks #31 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in CLDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,787,517 | 1,042,395 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $27,162,153 | 856,310 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,227,938 | 855,226 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $21,098,537 | 815,560 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $15,872,694 | 779,985 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $11,349,576 | 625,321 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,375,708 | 608,457 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $14,118,222 | 415,364 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,396,160 | 416,000 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $7,641,561 | 182,072 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,387,282 | 161,051 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,426,867 | 160,860 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,457,199 | 160,837 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,962,893 | 165,728 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $8,823,121 | 197,961 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,497,247 | 195,562 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,291,843 | 196,285 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,233,559 | 183,017 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $7,126,413 | 184,431 | Shares | Defined | 2022-02-07 | |
| No filing history on record for this holder in this stock. | ||||||